The merger realizes the shared strategic
goal of becoming the leading Global Medical Device and Medical
Technology Focused CRO
BILTHOVEN, Netherlands & MARLBOROUGH, Mass.-Tuesday 8 January 2019 [ AETOS Wire ]
(BUSINESS WIRE) -- Factory-CRO Group, a leading global contract research organization (CRO) focused on medical devices and in vitro diagnostics (IVDs), and Boston Biomedical Associates
(BBA) a premier full-service Medical Device/Biotechnology CRO and
Consultancy based in the United States announce that they have merged
the organizations.
The merger
further advances the shared strategic vision to become the leading
Global Medical Device and Medical Technology focused CRO. Following the
recent acquisitions of MileStone Research Organization, Five Corners,
and Clinical Device Group the Factory-CRO Group now has specialized
operations and expertise in the United States, Australia/New Zealand,
and Europe. This global expansion coupled with the diverse medical
therapeutic expertise provides a means to efficiently service clients.
“BBA is
excited to join Factory-CRO’s worldwide group as it will allow us to
expand our comprehensive service offering to our clients,” said Lauren
Baker, PhD, President and CEO of BBA. “The alignment of Factory-CRO and
BBA’s core values and approach to engagements combined with our
collective therapeutic competencies ensures that our clients now have
improved access to our global clinical trial execution resources, and
our regulatory and medical expertise.” Dr. Baker then added, “We are
able to fully support our clients as their needs evolve and they strive
to help patients globally.”
“We are
honored to have the BBA team join the Factory-CRO Group,” said Dirk
Meijer, MD, MSc,PhD, Factory-CRO CEO. “BBA’s ability to provide
CRO/Consultative service in North America was a missing link in our
global offerings.” Dr. Meijer then added, “Our clients have consistently
asked us to expand our offerings in North America. This merger allows
us to provide our specialized expertise and a continued commitment to
the highest level of customized service to a larger audience. Now we are
the only Medical Device and Medical Technology CRO that offers services
in United States, Europe, Australia and New Zealand. We operate from
our own offices located within each region housed with employees that
have refined expertise to meet our unique client needs.”
About Factory-CRO Group:
Factory-CRO Group is a leading, full-service contract research organization focused on the management of clinical studies for medical devices, IVDs, biologics and device-drug combination products internationally. Founded in 1992, the business offers a full suite of trial management services to its global client base across a broad range of therapeutic areas, including orthopedic, cardiovascular, dermatology and aesthetics. Current members of Factory-CRO Group are: BBA, Five Corners CRO, Milestone Research group and Factory-CRO.
Factory-CRO Group is a leading, full-service contract research organization focused on the management of clinical studies for medical devices, IVDs, biologics and device-drug combination products internationally. Founded in 1992, the business offers a full suite of trial management services to its global client base across a broad range of therapeutic areas, including orthopedic, cardiovascular, dermatology and aesthetics. Current members of Factory-CRO Group are: BBA, Five Corners CRO, Milestone Research group and Factory-CRO.
For more information about Factory-CRO, visit their website, www.factory-cro.com or contact Joris Bannenberg, MD, PhD, Factory-CRO’s CMO:
Joris Bannenberg, MD, PhDCMO
j.bannenberg@factory-cro.com
+31 30 229 2727 (x108)
About Boston Biomedical Associates:
Boston Biomedical Associates (BBA) is a premier full-service Medical Device/Biotechnology CRO and Consultancy firm. Founded in 2000, by Lauren Baker, Ph.D., this leading CRO has earned a reputation for its comprehensive approach to clinical trial execution services to its global client base across a broad range of therapeutic areas, including orthopedic, cardiovascular, endocrine and neurologic disorders.
Boston Biomedical Associates (BBA) is a premier full-service Medical Device/Biotechnology CRO and Consultancy firm. Founded in 2000, by Lauren Baker, Ph.D., this leading CRO has earned a reputation for its comprehensive approach to clinical trial execution services to its global client base across a broad range of therapeutic areas, including orthopedic, cardiovascular, endocrine and neurologic disorders.
For more information about BBA, visit their website, www.bbacro.com or contact Mack Rubley, PhD, BBA’s Vice President of Business Development and Marketing:
Mack D. Rubley, PhDVP, Business Development and Marketing
702-808-3494
mrubley@bbacro.com
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190107005358/en/
Contacts
Joris Bannenberg, MD, PhD
CMO
j.bannenberg@factory-cro.com
+31 30 229 2727 (x108)
Mack D. Rubley, PhD
VP, Business Development and Marketing
702-808-3494
mrubley@bbacro.com
